- Home
- ZH vs XOMA Comparison
ZH vs XOMA Comparison
Compare ZH & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZH
- XOMA
- Stock Information
- Founded
- ZH 2011
- XOMA 1981
- Country
- ZH China
- XOMA United States
- Employees
- ZH N/A
- XOMA N/A
- Industry
- ZH Business Services
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- ZH Consumer Discretionary
- XOMA Health Care
- Exchange
- ZH Nasdaq
- XOMA Nasdaq
- Market Cap
- ZH 387.2M
- XOMA 320.8M
- IPO Year
- ZH 2021
- XOMA N/A
- Fundamental
- Price
- ZH $3.58
- XOMA $28.59
- Analyst Decision
- ZH Strong Buy
- XOMA Strong Buy
- Analyst Count
- ZH 2
- XOMA 2
- Target Price
- ZH $6.00
- XOMA $78.50
- AVG Volume (30 Days)
- ZH 798.2K
- XOMA 18.9K
- Earning Date
- ZH 11-27-2024
- XOMA 11-05-2024
- Dividend Yield
- ZH N/A
- XOMA N/A
- EPS Growth
- ZH N/A
- XOMA N/A
- EPS
- ZH N/A
- XOMA N/A
- Revenue
- ZH $558,027,906.00
- XOMA $15,239,000.00
- Revenue This Year
- ZH N/A
- XOMA $456.45
- Revenue Next Year
- ZH $7.55
- XOMA $29.84
- P/E Ratio
- ZH N/A
- XOMA N/A
- Revenue Growth
- ZH N/A
- XOMA 277.95
- 52 Week Low
- ZH $2.55
- XOMA $14.27
- 52 Week High
- ZH $6.36
- XOMA $30.50
- Technical
- Relative Strength Index (RSI)
- ZH 46.23
- XOMA 53.55
- Support Level
- ZH $3.56
- XOMA $28.66
- Resistance Level
- ZH $3.71
- XOMA $30.50
- Average True Range (ATR)
- ZH 0.23
- XOMA 1.07
- MACD
- ZH -0.08
- XOMA 0.21
- Stochastic Oscillator
- ZH 12.50
- XOMA 55.56
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.